Admission to Trading Application

Summary by AI BETAClose X

Oxford Biomedica PLC has applied to the London Stock Exchange for the admission to trading of 92,381 ordinary shares, issued under its Long Term Incentive Plan, Sharesave Scheme, and Employee Share Option Scheme. These new ordinary shares are expected to be admitted to trading on March 9, 2026, and will rank equally with existing shares.

Disclaimer*

UK 100

Latest directors dealings